Nearly 63% of newly diagnosed patients have advanced colorectal cancer, which requires more aggressive treatment and reduces the associated 5-year survival rate.
Haytham Gareer, MD, PhD, MBA, FACS
Advertisement
Articles by Haytham Gareer, MD, PhD, MBA, FACS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
3
FDA Approves Lumateperone With Antidepressant Use for Major Depressive Disorder
4
Population Genomic Screening Improves Lipid Management in Familial Hypercholesterolemia
5
